+33 (0)6 32 55 85 48
Quantum Surgical receives NMPA market authorization for its Epione® robot to treat abdominal cancers in China
JFR 2023 – 13-16 octobre 2023.
Quantum Surgical obtains CE mark approval to treat patients with lung tumors using its Epione® robot
CIO 2023 – 22-24 September 2023
CIRSE 2023 9 -13 September 2023
Cancer: 50 patients treated with the Epione® robot from Quantum Surgical at the Hospices Civils de Lyon
First patient treated in the United States with Quantum Surgical’s Epione® robot
FDA clears Quantum Surgical’s Epione® robot for all abdominal cancers
Quantum Surgical announces the ongoing clinical trial at Gustave Roussy to extend the use of its medical robot Epione® in treating lung metastases
Robert Thompson and Joseph de Vivo have joined Quantum Surgical’s Board of Directors
Quantum Surgical is recruiting
At Quantum Surgical, we are recruiting the brightest minds and most creative innovators that thrive in a start-up environment.